论文部分内容阅读
重症糖尿病经常合并肺结核,后者又常发展为慢性肺心病,近年来,我国对蝮蛇抗栓酶的药理作用屡有报道,受其启示,我们针对重症糖尿病合并肺心病的病理生理,选用蝮蛇抗栓酶治疗,疗效显著。现将结果报道如下: 1 资料与方法 1.1 一般资料 本组病例系1993年10月～1995年12月期间,收治重症糖尿病合并肺心病共38例。 1.2 研究方法 将38例患者随机分为治疗组(常规综合治疗加蝮蛇抗栓酶)及对照组(常规综合治疗)各19例。治疗组:男7例,女12例,55岁以下8例,55～71岁11例,均符合我国糖尿病、肺心病诊断标准,症状严重程度不一。对照组:与治疗组基本相似。治疗方法:38例
Severe diabetes mellitus is often associated with pulmonary tuberculosis, the latter often develop chronic pulmonary heart disease, in recent years, our pharmacological effects of viper antithrombolytic enzyme have been repeatedly reported, by its revelation, we focus on the pathophysiology of severe diabetes complicated with pulmonary heart disease, use 蝮Snake antithrombotic treatment, a significant effect. The results are reported as follows: 1 Materials and Methods 1.1 General Information The group of cases from October 1993 to December 1995 period, admitted to severe diabetes combined with pulmonary heart disease in 38 cases. 1.2 Methods of study 38 patients were randomly divided into treatment group (conventional combined treatment plus vomiting antithrombotic enzyme) and control group (conventional comprehensive treatment) in 19 cases. Treatment group: 7 males and 12 females, 8 cases under 55 years old, 11 cases 55 to 71 years old, all in line with China’s diabetes, pulmonary heart disease diagnostic criteria, the severity of the symptoms vary. Control group: similar to the treatment group. Treatment: 38 cases